Appropriate Biological matrix for BA/BE studies [Bioanalytics]

posted by Ohlbe – France, 2010-10-01 16:39 (5750 d 11:58 ago) – Posting: # 5973
Views: 8,144

Dear all,

❝ Whole blood makes only sense if the drug is extensively bound to erythrocytes and essentially no concentrations would be found in plasma (one of the rare examples is chlorthalidone).


I think regulators would expect whole blood to be used for some drugs which are traditionally measured in whole blood for therapeutic drug monitoring, such as ciclosporin or tacrolimus, independently on whether they can nowadays be measured in plasma or not. Bortezomib would probably be a candidate for whole blood too.

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
282 visitors (1 registered, 281 guests [including 35 identified bots]).
Forum time: 04:38 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5